Additionally, treatment of ovarian cancer cells with ABC294640 caused increased expression of BAX [46], thereby tilting the balance of the bcl-2 family of proteins, which are known to contribute to gemcitabine resistance [47], in the pro-apoptotic direction. The gene discussed is BCL2; the disease is ovarian cancer.